HOME >> BIOLOGY >> NEWS
Prominent North Shore-LIJ physician-researcher brings science to the masses with new book

MANHASSET, NY Though most people have not heard of it, the mysterious and deadly syndrome called severe sepsis is the third leading cause of death for hospitalized patients in the developed world. In the United States, it kills approximately 215,000 people every year, a number exceeded only by heart disease and cancer. While scientific knowledge of severe sepsis has grown in recent years, public awareness remains low. In his new book Fatal Sequence: The Killer Within, Kevin J. Tracey, MD, unravels in terms accessible to the general public the mystery of this silent killer by telling the captivating story of a young patient who changed his life.

A world-renowned physician-scientist who has dedicated his career to studying the inflammatory response and how it can go awry, Dr. Tracey is head of the Susan and Herman Merinoff Center for Patient-Oriented Research at the Institute for Medical Research of the North Shore-Long Island Jewish Health System in Manhasset, NY. He has been credited with initiating a new field of investigation based on therapeutically targeting systemic inflammation. He first outlined his breakthrough work, called "The Inflammatory Reflex," in a January 2003 Nature article (published online in December 2002).

While training to be a neurosurgeon 20 years ago, Dr. Tracey had no idea how dramatically the course of his life would change when a severely burned baby girl was admitted under his care. The infant developed severe sepsis, which ultimately took her life a month later. After the most dramatic physical and emotional roller-coaster ride of Dr. Tracey's life, the recurring nightmares of her death began, and so did his passion to find out what killed her.

He immediately began researching the syndrome and in the process launched his career in biomedical research. Severe sepsis begins when the body's natural immune response to an insult or infection gets so out of control that it starts to impair the functioning of major org
'"/>

Contact: Christina Verni
cverni@nshs.edu
516-562-1232
North Shore-Long Island Jewish (LIJ) Health System
29-Mar-2005


Page: 1 2

Related biology news :

1. Prominent ecologists to discuss results of worlds largest international ecological meeting
2. Prominent physicist Freeman Dyson to speak at NJIT: Promises and perils of genetic engineering
3. Changing climate will challenge Northeast agriculture, CU expert warns
4. Northern forests less effective than tropical forests in reducing global warming
5. Genomatix expands operations in North America
6. Overfishing great sharks wiped out North Carolina bay scallop fishery
7. Iowa State University botanists identify new species of North American bamboo
8. Climate changes, Cod collapse have altered North Atlantic ecosystems
9. Altered ocean currents disturb ecosystem off Northern California and Oregon coast
10. Hotspots of mercury contamination identified in eastern North America
11. UGA study identifies North American wild bird species that could transmit bird flu

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/15/2016)... , June 15, 2016 ... report titled "Gesture Recognition Market by Application Market - Global Industry ... - 2024". According to the report, the  global gesture ... in 2015 and is estimated to grow at ... billion by 2024.  Increasing application of ...
(Date:6/2/2016)... , June 2, 2016 The Department ... has awarded the 44 million US Dollar project, for the ... Vehicle Plates including Personalization, Enrolment, and IT Infrastructure , ... in the production and implementation of Identity Management Solutions. Numerous ... however Decatur was selected for the ...
(Date:5/20/2016)... 2016  VoiceIt is excited to announce its ... By working together, VoiceIt and VoicePass will ... VoicePass take slightly different approaches to voice biometrics, ... and usability. ... partnership. "This marketing and technology partnership ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)... NEW YORK , June, 23, 2016  The ... students to envision new ways to harness living systems ... of Modern Art (MoMA) in New York ... more than 130 participating students, showcased projects at MoMA,s ... included Paola Antonelli , MoMA,s senior curator of ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... regulatory and technical consulting, provides a free webinar on Performing Quality ... 13, 2016 at 12pm CT at no charge. , Incomplete investigations are still ...
Breaking Biology Technology:
Cached News: